Side Effects of Intravesical BCG and Chemotherapy for Bladder Cancer: What They Are and How to Manage Them

George E. Koch, Woodson W. Smelser, Sam S. Chang

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

Intravesical therapy for nonmuscle invasive bladder cancer decreases recurrence and progression but carries a high risk of side effects, which limit patient adherence. Appropriate management of the toxicities from intravesical therapy requires consideration of the agent used, the side effects experienced, and the timing of those side effects. Management strategies for intravesical toxicities ideally improve patient tolerance without sacrificing oncologic outcomes. This review aims to provide a comprehensive overview of the available evidence regarding the side effects of intravesical therapies for nonmuscle invasive bladder cancer and to propose practical strategies for toxicity management.

Original languageEnglish
Pages (from-to)11-20
Number of pages10
JournalUrology
Volume149
DOIs
StatePublished - Mar 2021

Fingerprint

Dive into the research topics of 'Side Effects of Intravesical BCG and Chemotherapy for Bladder Cancer: What They Are and How to Manage Them'. Together they form a unique fingerprint.

Cite this